216 related articles for article (PubMed ID: 16926574)
1. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
Halvorson KG; Sevcik MA; Ghilardi JR; Rosol TJ; Mantyh PW
Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
[TBL] [Abstract][Full Text] [Related]
2. [Bone cancer pain: from preclinical pharmacology to clinical trials].
Montiel-Ruiz RM; Acosta-González RI; Jiménez Andrade JM
Gac Med Mex; 2013; 149(2):204-11. PubMed ID: 23652187
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms that generate and maintain bone cancer pain.
Mantyh PW; Hunt SP
Novartis Found Symp; 2004; 260():221-38; discussion 238-40, 277-9. PubMed ID: 15283453
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin diminishes advanced bone cancer pain.
Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
[TBL] [Abstract][Full Text] [Related]
5. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.
Sevcik MA; Luger NM; Mach DB; Sabino MA; Peters CM; Ghilardi JR; Schwei MJ; Röhrich H; De Felipe C; Kuskowski MA; Mantyh PW
Pain; 2004 Sep; 111(1-2):169-80. PubMed ID: 15327821
[TBL] [Abstract][Full Text] [Related]
6. Tumor-bone cellular interactions in skeletal metastases.
Chirgwin JM; Mohammad KS; Guise TA
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):308-18. PubMed ID: 15615499
[TBL] [Abstract][Full Text] [Related]
7. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of bone cancer pain.
Sabino MA; Mantyh PW
J Support Oncol; 2005; 3(1):15-24. PubMed ID: 15724942
[TBL] [Abstract][Full Text] [Related]
9. Bone cancer pain.
Clohisy DR; Mantyh PW
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S279-88. PubMed ID: 14600620
[TBL] [Abstract][Full Text] [Related]
10. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
Vessella RL; Corey E
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6285s-6290s. PubMed ID: 17062715
[TBL] [Abstract][Full Text] [Related]
11. Painful osseous metastases.
Smith HS
Pain Physician; 2011; 14(4):E373-403. PubMed ID: 21785487
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and treatment for bone metastases.
Clines GA; Guise TA
Clin Adv Hematol Oncol; 2004 May; 2(5):295-302. PubMed ID: 16163196
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA; Guise TA
Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
[TBL] [Abstract][Full Text] [Related]
14. Biology of bone cancer pain.
Goblirsch MJ; Zwolak PP; Clohisy DR
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6231s-6235s. PubMed ID: 17062706
[TBL] [Abstract][Full Text] [Related]
15. Bone cancer pain.
Clohisy DR; Mantyh PW
Cancer; 2003 Feb; 97(3 Suppl):866-73. PubMed ID: 12548588
[TBL] [Abstract][Full Text] [Related]
16. Endothelin and the tumorigenic component of bone cancer pain.
Peters CM; Lindsay TH; Pomonis JD; Luger NM; Ghilardi JR; Sevcik MA; Mantyh PW
Neuroscience; 2004; 126(4):1043-52. PubMed ID: 15207337
[TBL] [Abstract][Full Text] [Related]
17. Bone cancer pain.
Jimenez-Andrade JM; Mantyh WG; Bloom AP; Ferng AS; Geffre CP; Mantyh PW
Ann N Y Acad Sci; 2010 Jun; 1198():173-81. PubMed ID: 20536932
[TBL] [Abstract][Full Text] [Related]
18. [A mechanism based understanding of cancer pain and development of novel strategies of cancer pain treatment].
Kawamata T; Namiki A
Masui; 2008 Jan; 57(1):39-50. PubMed ID: 18214004
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy.
Pinski J; Dorff TB
Eur J Cancer; 2005 Apr; 41(6):932-40. PubMed ID: 15808959
[TBL] [Abstract][Full Text] [Related]
20. The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
Yonou H; Ochiai A; Ashimine S; Maeda H; Horiguchi Y; Yoshioka K; Ogawa Y; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(9):999-1009. PubMed ID: 17440967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
